(Q46255912)

20 December 2017

title

Apparent seizure and atrial fibrillation associated with paliperidone (English)

1 reference

20 December 2017

0 references

1 reference

Rebekah A Schneider

1

1 reference

20 December 2017

Mitsi H Lizer

series ordinal

2

1 reference

20 December 2017

publication date

1 November 2008

1 reference

20 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

20 December 2017

volume

65

1 reference

20 December 2017

issue

22

1 reference

20 December 2017

page(s)

2122-2125

1 reference

20 December 2017

Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

A method for estimating the probability of adverse drug reactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

Effects of psychotropic drugs on seizure threshold

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

Effects of risperidone in overdose

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070615

31 March 2020

Identifiers

DOI

10.2146/AJHP070615

1 reference

20 December 2017

1 reference

20 December 2017